[New therapeutic application of thalidomide].
Saano
V
V
Department of Pharmacology and Toxicology, University of Kuopio, Finland.
D001327:Autoimmune Diseases / Q000188:drug therapy*; D003093:Colitis, Ulcerative / Q000188:drug therapy; D004892:Erythema Multiforme / Q000188:drug therapy; D005260:Female; D015614:Histiocytosis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008010:Lichen Planus / Q000188:drug therapy; D008297:Male; D010201:Panniculitis, Nodular Nonsuppurative / Q000188:drug therapy; D011247:Pregnancy; D018570:Risk Assessment; D012507:Sarcoidosis / Q000188:drug therapy; D013792:Thalidomide / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D013792:Thalidomide
Talidomidin uusi tuleminen.